These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32026193)
1. Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study. Chen L; Han X; Li Y; Zhang C; Xing X Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1231-1238. PubMed ID: 32026193 [TBL] [Abstract][Full Text] [Related]
2. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study. Chen L; Han X; Li YL; Zhang C; Xing X BMC Infect Dis; 2020 Aug; 20(1):628. PubMed ID: 32842994 [TBL] [Abstract][Full Text] [Related]
4. Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013-2019. Chen L; Han XD; Li YL; Zhang CX; Xing XQ Infect Dis Poverty; 2020 Apr; 9(1):42. PubMed ID: 32321576 [TBL] [Abstract][Full Text] [Related]
5. Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis. Venkatesan S; Myles PR; Leonardi-Bee J; Muthuri SG; Al Masri M; Andrews N; Bantar C; Dubnov-Raz G; Gérardin P; Koay ESC; Loh TP; Memish Z; Miller E; Oliva ME; Rath BA; Schweiger B; Tang JW; Tran D; Vidmar T; Waight PA; Nguyen-Van-Tam JS Clin Infect Dis; 2017 May; 64(10):1328-1334. PubMed ID: 28199524 [TBL] [Abstract][Full Text] [Related]
6. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. Venkatesan S; Myles PR; Bolton KJ; Muthuri SG; Al Khuwaitir T; Anovadiya AP; Azziz-Baumgartner E; Bajjou T; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Chinbayar T; Cilloniz C; Denholm JT; Dominguez SR; Duarte PAD; Dubnov-Raz G; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hu XY; Islam QT; Jiménez MF; Keijzers G; Khalili H; Kusznierz G; Kuzman I; Langenegger E; Lankarani KB; Leo YS; Libster RP; Linko R; Madanat F; Maltezos E; Mamun A; Manabe T; Metan G; Mickiene A; Mikić D; Mohn KGI; Oliva ME; Ozkan M; Parekh D; Paul M; Rath BA; Refaey S; Rodríguez AH; Sertogullarindan B; Skręt-Magierło J; Somer A; Talarek E; Tang JW; To K; Tran D; Uyeki TM; Vaudry W; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS J Infect Dis; 2020 Jan; 221(3):356-366. PubMed ID: 31314899 [TBL] [Abstract][Full Text] [Related]
7. Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study. Choi SH; Kim T; Park KH; Kwak YG; Chung JW; Lee MS Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1673-1677. PubMed ID: 28417272 [TBL] [Abstract][Full Text] [Related]
8. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments. Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583 [TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibitors for critically ill children with influenza. Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847 [TBL] [Abstract][Full Text] [Related]
10. Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus. Zheng S; Tang L; Gao H; Wang Y; Yu F; Cui D; Xie G; Yang X; Zhang W; Ye X; Zhang Z; Wang X; Yu L; Zhang Y; Yang S; Liang W; Chen Y; Li L Clin Infect Dis; 2018 Mar; 66(7):1054-1060. PubMed ID: 29077848 [TBL] [Abstract][Full Text] [Related]
11. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405 [TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019. Chen L; Han X; Li Y; Zhang C; Xing X Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1633-1643. PubMed ID: 33677754 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study. Cohen R; Babushkin F; Geller K; Finn T PLoS One; 2019; 14(3):e0214517. PubMed ID: 30921408 [TBL] [Abstract][Full Text] [Related]
14. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. Muthuri SG; Myles PR; Venkatesan S; Leonardi-Bee J; Nguyen-Van-Tam JS J Infect Dis; 2013 Feb; 207(4):553-63. PubMed ID: 23204175 [TBL] [Abstract][Full Text] [Related]
15. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes. Katzen J; Kohn R; Houk JL; Ison MG Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487 [TBL] [Abstract][Full Text] [Related]
16. The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia. Chen L; Han X; Li Y; Zhang C; Xing X Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):55. PubMed ID: 34429126 [TBL] [Abstract][Full Text] [Related]
17. Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With Influenza. Lee N; Smith SW; Hui DSC; Ye M; Zelyas N; Chan PKS; Drews SJ; Zapernick L; Wong R; Labib M; Shokoples S; Eurich DT Clin Infect Dis; 2021 Dec; 73(11):e4369-e4374. PubMed ID: 32827251 [TBL] [Abstract][Full Text] [Related]
18. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus. Huang SF; Fung CP; Perng DW; Wang FD J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. Cao B; Gao H; Zhou B; Deng X; Hu C; Deng C; Lu H; Li Y; Gan J; Liu J; Li H; Zhang Y; Yang Y; Fang Q; Shen Y; Gu Q; Zhou X; Zhao W; Pu Z; Chen L; Sun B; Liu X; Hamilton CD; Li L Crit Care Med; 2016 Jun; 44(6):e318-28. PubMed ID: 26934144 [TBL] [Abstract][Full Text] [Related]
20. Widespread use of neuraminidase inhibitors in Japan. Sugaya N J Infect Chemother; 2011 Oct; 17(5):595-601. PubMed ID: 21850418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]